FDA Issues New Draft Guidance on Clinical Evaluation of Software as Medical Device
The U.S. Food and Drug Administration released updated guidance on May 13, 2024, that sets new expectations for…
Read More →Federal drug and device approvals, safety alerts, and regulatory guidance.
The U.S. Food and Drug Administration released updated guidance on May 13, 2024, that sets new expectations for…
Read More →The FDA has begun reviewing new adverse event reports tied to a prescription medication already on the market. Agency…
Read More →The FDA released updated guidance in May 2024 that refines how software functions for chronic disease management are…
Read More →The U.S. Food and Drug Administration approved the first vaccine against respiratory syncytial virus for adults aged…
Read More →CDC Updates 2024 Adult Immunization Schedule With RSV Recommendations for Older Adults
Read More →